Science ❯ Medicine ❯ Pharmacology

Drug Development

Targeted Protein Degradation Technologies Exercise Mimicking Pills Clinical Research Seizure Medications Drug Screening CXCR4 Inhibitors BCR::ABL1 Inhibitors Clinical Studies Combination Therapy Precision Medicine

Mount Sinai's V2P AI Predicts Disease Type From Genetic Mutations

The Nature Communications study reports improved variant ranking in patient tests.

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Cambridge Scientists Grow Self-Organising ‘Hematoids’ That Produce Human Blood Stem Cells